# Ariad Pharmaceuticals - Inspection Records

Source: https://www.keypedia.com/companies/ariad-pharmaceuticals/b8bb8a71-2f59-4440-b7b4-0d42aee90540

> Inspection records and compliance data for Ariad Pharmaceuticals in Cambridge, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Ariad Pharmaceuticals
- FEI Number: 1000513233
- City: Cambridge
- State: Massachusetts
- Country Name: United States
- Address Line 1: 40 Landsdowne St
- Zip Code: 02139

## Related Documents

- [WARNING_LETTER - Ariad Pharmaceuticals - Unknown Date](https://www.keypedia.com/records/warning_letter/ariad-pharmaceuticals/2c67b99a-1c7a-4269-b3e8-f797c72c6591) — source: FDA, date: Invalid Date
- [483 - Ariad Pharmaceuticals - 2017-05-31](https://www.keypedia.com/records/483/ariad-pharmaceuticals/8ec8d934-b117-4749-9a73-fc7d3cf87075) — source: FDA, date: May 31, 2017
- [FDA Inspection 1012179 - Ariad Pharmaceuticals - 2017-05-31](https://www.keypedia.com/records/fda_inspections/ariad-pharmaceuticals/52153031-7a82-4ebe-b201-c836ddcc47b9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2017
- [FDA Inspection 1012179 - Ariad Pharmaceuticals - 2017-05-31](https://www.keypedia.com/records/fda_inspections/ariad-pharmaceuticals/f0b6ac38-8a56-486a-b06d-b1ed14cb1f6d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2017
- [FDA Inspection 996407 - Ariad Pharmaceuticals - 2016-12-02](https://www.keypedia.com/records/fda_inspections/ariad-pharmaceuticals/4f745ae5-616f-41bf-8575-e24c60785069) — classification: No Action Indicated (NAI), source: FDA, date: December 2, 2016
- [FDA Inspection 901088 - Ariad Pharmaceuticals - 2014-10-16](https://www.keypedia.com/records/fda_inspections/ariad-pharmaceuticals/31f7883e-8bbf-4329-b854-7a3219e8d486) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2014
- [FDA Inspection 901088 - Ariad Pharmaceuticals - 2014-10-16](https://www.keypedia.com/records/fda_inspections/ariad-pharmaceuticals/9b3d6560-424c-4101-8bf6-0840548d7eed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2014
- [FDA Inspection 799052 - Ariad Pharmaceuticals - 2012-09-13](https://www.keypedia.com/records/fda_inspections/ariad-pharmaceuticals/ed410cec-e547-46b4-bbb4-5cb9c13c9a0a) — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2012

## Related Companies

- [Buckeye International Inc](https://www.keypedia.com/companies/buckeye-international-inc/01799cae-da24-4d86-9a28-d25a72c9bc8b)
- [Pharbil Waltrop Gmbh](https://www.keypedia.com/companies/pharbil-waltrop-gmbh/f3455dea-04cf-4c53-ab8b-3fcddc45fb4c)
- [G S Cosmeceutical USA Inc](https://www.keypedia.com/companies/g-s-cosmeceutical-usa-inc/02e5e566-9934-4417-9659-f041ee537843)
- [Columbia Cosmetics Manufacturing, Inc.](https://www.keypedia.com/companies/columbia-cosmetics-manufacturing-inc/c6e32c25-080a-4901-8391-8716d6517687)
- [Spectrum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/spectrum-pharmaceuticals-inc/d2be8240-3764-497f-8d0d-fbedb45f3053)
- [Bell Pharmaceuticals, Inc](https://www.keypedia.com/companies/bell-pharmaceuticals-inc/bb92f552-7a5a-4a84-b282-4310321b816b)
- [Ajanta Pharma Ltd.](https://www.keypedia.com/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7)
- [Medline Industries, Inc.](https://www.keypedia.com/companies/medline-industries-inc/ab99df74-d4aa-44f4-aed8-fcb2d3e45280)
- [Marksans Pharma Limited](https://www.keypedia.com/companies/marksans-pharma-limited/0855d225-2181-468a-a51c-c479608c1c92)
- [McKenna Labs Inc](https://www.keypedia.com/companies/mckenna-labs-inc/a0956f9d-e7ea-4bf6-ac78-77140586f684)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/victoria-m-daddeo/f1832c5e-d242-4e1a-8c30-4c951c3976ea)
- [Arizona Market President](https://www.keypedia.com/people/john-p-mistler/7b2d423d-46cc-48bd-aa5a-4ae794888060)
- [Director](https://www.keypedia.com/people/george-tidmarsh/b9977f2c-595d-429e-abb0-8e302a2133b6)